These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1578129

  • 1. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes.
    Wang Y, Smith JA, Gefter ML, Perkins DL.
    J Immunol; 1992 May 15; 148(10):3034-41. PubMed ID: 1578129
    [Abstract] [Full Text] [Related]

  • 2. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E, Horváth A, Gogolák P, Tóth GK, Fazekas G, Fridkin M, Pecht I.
    Eur J Immunol; 1997 Dec 15; 27(12):3105-14. PubMed ID: 9464794
    [Abstract] [Full Text] [Related]

  • 3. Immunodominance does not result from peptide competition for MHC class II presentation.
    Lo-Man R, Langeveld JP, Martineau P, Hofnung M, Meloen RH, Leclerc C.
    J Immunol; 1998 Feb 15; 160(4):1759-66. PubMed ID: 9469434
    [Abstract] [Full Text] [Related]

  • 4. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.
    Harris DP, Vordermeier HM, Arya A, Moreno C, Ivanyi J.
    Immunology; 1995 Apr 15; 84(4):555-61. PubMed ID: 7790029
    [Abstract] [Full Text] [Related]

  • 5. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.
    Nikcevich KM, Kopielski D, Finnegan A.
    J Immunol; 1994 Aug 01; 153(3):1015-26. PubMed ID: 7517970
    [Abstract] [Full Text] [Related]

  • 6. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C, Whiteley PE, Cameron PM, Freed DC, Pressey A, Chen SL, Garni-Wagner B, Fang C, Zaller DM, Wicker LS, Blum JS.
    J Immunol; 1999 Dec 15; 163(12):6413-23. PubMed ID: 10586031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B, Manickasundari M, Fraga E, Singh B.
    J Immunol; 1991 Jul 15; 147(2):383-90. PubMed ID: 1649218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH, Takeshita T, Pendleton CD, Houghten RA, Sadegh-Nasseri S, Racioppi L, Berzofsky JA, Germain RN.
    J Immunol; 1993 Jan 15; 150(2):331-41. PubMed ID: 8093457
    [Abstract] [Full Text] [Related]

  • 11. Immunodominance: intramolecular competition between T cell epitopes.
    Perkins DL, Berriz G, Kamradt T, Smith JA, Gefter ML.
    J Immunol; 1991 Apr 01; 146(7):2137-44. PubMed ID: 1706388
    [Abstract] [Full Text] [Related]

  • 12. Immunological activity of covalently linked T-cell epitopes.
    Ria F, Chan BM, Scherer MT, Smith JA, Gefter ML.
    Nature; 1990 Jan 25; 343(6256):381-3. PubMed ID: 1689012
    [Abstract] [Full Text] [Related]

  • 13. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 25; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 14. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J, Sette A, Sidney J, Appella E, Ehrhardt C, Fuchs S, Adorini L.
    J Immunol; 1991 Jul 01; 147(1):198-204. PubMed ID: 1711074
    [Abstract] [Full Text] [Related]

  • 15. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH, Lien LL, Benacerraf B, Rock KL.
    J Immunol; 1993 May 15; 150(10):4206-17. PubMed ID: 8482833
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J.
    J Immunol; 1998 Feb 15; 160(4):1555-64. PubMed ID: 9469410
    [Abstract] [Full Text] [Related]

  • 19. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L, Guéry JC, Fuchs S, Ortiz-Navarrete V, Hämmerling GJ, Momburg F.
    J Immunol; 1993 Oct 01; 151(7):3576-86. PubMed ID: 7690807
    [Abstract] [Full Text] [Related]

  • 20. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S, Yang Y, Sadegh-Nasseri S, Ashwell JD.
    J Immunol; 1993 Mar 15; 150(6):2211-21. PubMed ID: 8450208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.